BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19483272)

  • 1. [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].
    Michigami T
    Clin Calcium; 2009 Jun; 19(6):785-92. PubMed ID: 19483272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperphosphoremia and hypophosphoremia].
    Kuntziger H; Altman JJ
    Rev Prat; 1989 Apr; 39(11):949-53. PubMed ID: 2717867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypophosphatemia of a genetic origin].
    Escoubet B; Silve C
    Nephrologie; 1992; 13(3):115-21. PubMed ID: 1641053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophosphatemia: an evidence-based problem-solving approach to clinical cases.
    Assadi F
    Iran J Kidney Dis; 2010 Jul; 4(3):195-201. PubMed ID: 20622306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of hyperphosphatemia and hypophosphatemia.
    Bourke E; Yanagawa N
    Clin Lab Med; 1993 Mar; 13(1):183-207. PubMed ID: 8462260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
    Endo I
    Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging topics in pediatric bone and mineral disorders 2008.
    McKay CP; Portale A
    Semin Nephrol; 2009 Jul; 29(4):370-8. PubMed ID: 19615558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
    Fukumoto S
    Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphosphatemia: effects on bone metabolism and cardiovascular risk.
    Caudarella R; Vescini F; Buffa A; Francucci CM
    J Endocrinol Invest; 2007; 30(6 Suppl):29-34. PubMed ID: 17721071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiopathology of Phosphate Disorders.
    Portales-Castillo I; Rieg T; Khalid SB; Nigwekar SU; Neyra JA
    Adv Kidney Dis Health; 2023 Mar; 30(2):177-188. PubMed ID: 36868732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process.
    Garabedian M
    Curr Opin Pediatr; 2007 Aug; 19(4):488-91. PubMed ID: 17630616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roles of hyperphosphatemia in vascular calcification].
    Shioi A; Nishizawa Y
    Clin Calcium; 2009 Feb; 19(2):180-5. PubMed ID: 19182356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibroblast growth factor 23--a phosphate regulating hormone].
    Beck-Nielsen SS; Pedersen SM; Kassem M; Rasmussen LM
    Ugeskr Laeger; 2010 May; 172(20):1521-7. PubMed ID: 20483099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphate is a uremic toxin.
    Burke SK
    J Ren Nutr; 2008 Jan; 18(1):27-32. PubMed ID: 18089440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of hypophosphatemia.
    Ito N; Hidaka N; Kato H
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101851. PubMed ID: 38087658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23].
    Shimizu Y; Fukumoto S
    Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders of phosphate metabolism.
    Leung J; Crook M
    J Clin Pathol; 2019 Nov; 72(11):741-747. PubMed ID: 31467040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of hyperphosphatemia in patients with chronic kidney disease].
    Savica V; Santoro D; Monardo P; Mallamace A; Bellinghieri G
    G Ital Nefrol; 2009; 26 Suppl 46():58-61. PubMed ID: 19644820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine crises. Hypophosphatemia and hyperphosphatemia.
    Peppers MP; Geheb M; Desai T
    Crit Care Clin; 1991 Jan; 7(1):201-14. PubMed ID: 2007215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.